Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4090479
Max Phase: Preclinical
Molecular Formula: C40H45N6NaO10S
Molecular Weight: 802.91
Molecule Type: Small molecule
Associated Items:
ID: ALA4090479
Max Phase: Preclinical
Molecular Formula: C40H45N6NaO10S
Molecular Weight: 802.91
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNS(=O)(=O)c2cccc3c(N(C)C)cccc23)O[C@@](OCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)(C(=O)[O-])C[C@@H]1O.[Na+]
Standard InChI: InChI=1S/C40H46N6O10S.Na/c1-25(47)42-36-33(48)22-40(39(51)52,55-21-9-20-46-24-31(43-44-46)28-18-16-27(17-19-28)26-10-5-4-6-11-26)56-38(36)37(50)34(49)23-41-57(53,54)35-15-8-12-29-30(35)13-7-14-32(29)45(2)3;/h4-8,10-19,24,33-34,36-38,41,48-50H,9,20-23H2,1-3H3,(H,42,47)(H,51,52);/q;+1/p-1/t33-,34+,36+,37+,38+,40+;/m0./s1
Standard InChI Key: GUEHGUAIVYOEQH-FJQTYYRKSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 802.91 | Molecular Weight (Monoisotopic): 802.2996 | AlogP: 2.37 | #Rotatable Bonds: 16 |
Polar Surface Area: 225.67 | Molecular Species: ACID | HBA: 13 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.81 | CX Basic pKa: 4.63 | CX LogP: 1.28 | CX LogD: -0.40 |
Aromatic Rings: 5 | Heavy Atoms: 57 | QED Weighted: 0.08 | Np Likeness Score: -0.52 |
1. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.. (2017) Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion., 60 (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111] |
Source(1):